|
Volumn 32, Issue 3, 2015, Pages 205-207
|
Management of latent tuberculosis infection: An evidence-based approach
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ISONIAZID;
ISONIAZID PLUS RIFAMPICIN;
TUBERCULIN;
TUMOR NECROSIS FACTOR ALPHA;
ALGORITHM;
CELLULAR IMMUNITY;
CONTROL STRATEGY;
EDITORIAL;
ENZYME LINKED IMMUNOSPOT ASSAY;
EVIDENCE BASED PRACTICE;
HIGH RISK POPULATION;
HUMAN;
IMMUNOCOMPROMISED PATIENT;
INTERFERON GAMMA RELEASE ASSAY;
LATENT TUBERCULOSIS;
MYCOBACTERIUM TUBERCULOSIS TEST KIT;
PREDICTIVE VALUE;
PROPHYLAXIS;
RESEARCH;
SKIN INDURATION;
THORAX RADIOGRAPHY;
TUBERCULIN TEST;
TUBERCULOSIS CONTROL;
|
EID: 84929300105
PISSN: 09702113
EISSN: 0974598X
Source Type: Journal
DOI: 10.4103/0970-2113.156210 Document Type: Editorial |
Times cited : (29)
|
References (10)
|